v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net income $ 21,779 $ 1,730
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 37,761 29,139
Reduction in the carrying amount of right-of-use assets 10,722 10,080
Amortization of deferred contract acquisition costs 48,394 41,528
Accretion of discount on marketable investments (2,294) (5,325)
Provision for credit losses 600 945
Stock-based compensation 65,644 81,104
Amortization of discount and issuance costs on convertible senior notes 1,792 2,680
Impairment charges of long-lived assets 8,518 835
Interest on finance lease obligations 345 548
Deferred taxes - excluding tax benefit from acquisition 142 33
Other 1,079 (201)
Changes in operating assets and liabilities:    
Accounts receivable (11,123) (13,608)
Prepaid expenses and other current assets (7,941) 2,854
Deferred contract acquisition costs (66,809) (56,181)
Other assets 2,831 2,552
Accounts payable 7,891 3,853
Accrued and other current liabilities (8,500) (8,096)
Deferred revenue (4,727) (11,522)
Other liabilities (including non-current portions of operating and finance lease liabilities) (106) 497
Net cash provided by operating activities 105,998 83,445
Cash flows from investing activities:    
Purchases of marketable investments (199,648) (315,146)
Proceeds from sales of marketable investments 62,806 90,502
Proceeds from maturities of marketable investments 135,764 442,655
Purchases of property and equipment (22,891) (8,218)
Capitalization of internal-use software development costs (18,473) (18,730)
Net cash (used in) provided by investing activities (42,442) 191,063
Cash flows from financing activities:    
Repayment of outstanding 2025 convertible senior notes at maturity 0 (434,405)
Proceeds from exercise of common stock options 445 30
Proceeds from sale of common stock under ESPP 7,008 7,921
Cash paid for repurchase of the Company's common stock (100,011) 0
Principal repayment on financing liability (10,779) 0
Payment of finance lease liabilities (4,924) (4,671)
Net cash used in financing activities (108,261) (431,125)
Net decrease in cash, cash equivalents and restricted cash (44,705) (156,617)
Cash, cash equivalents and restricted cash:    
Total cash, cash equivalents and restricted cash 234,131 364,185
Total cash, cash equivalents and restricted cash 189,426 207,568
Supplemental disclosures of cash flow data:    
Cash paid for interest 4,856 5,428
Cash paid for income taxes 1,266 2,923
Non-cash investing and financing activities:    
Maintenance services purchased through financing 48,276 0
Equipment purchased and unpaid at period-end 8,390 13,058
Stock-based compensation included in capitalized software development costs 4,568 4,928
Reconciliation of Cash, Cash Equivalents and Restricted Cash to the Condensed Consolidated Balance Sheets - Beginning of Period:    
Cash and cash equivalents 232,084 362,546
Restricted cash in other assets 2,047 1,639
Total cash, cash equivalents and restricted cash 234,131 364,185
Cash and cash equivalents 187,305 205,479
Restricted cash in other assets 2,121 2,089
Total cash, cash equivalents and restricted cash $ 189,426 $ 207,568